Bioequivalence and Bioavailability Forum • OT: A choice between

OT: A choice between [Design Issues]

posted by BEQool – 2024-10-23 15:17 (251 d 02:23 ago) – Posting: # 24248
Views: 7,208

Hello Helmut,

of course I unfortunately dont know the answers to your questions but

❝ [...] or PEs by model 3 (i.e., the conventional one with any group terms)? What would an assessor conclude from any of those? Even if they would calculate the CI of groups separately, likely they would overlap. So what?

Isnt it so that if we detect Group*Treatment interaction, the CIs of groups seperately very likely wouldnt overlap? That is why we detect an interaction?

BEQool

Complete thread:

Possible reasons for group effect GM 2019-07-20 07:36
- Group “effect” Helmut 2019-07-20 14:02
- Possible reasons for group effect ElMaestro 2019-07-20 19:20
  - Possible reasons for group effect GM 2019-07-23 06:23
    - “Group-by-Treatment Interaction” Helmut 2019-07-23 10:32
      - “Group-by-Treatment Interaction” BEQool 2024-10-22 12:39
        
        “Group-by-Treatment Interaction” Helmut 2024-10-22 12:47
        
        OT: A choice between mittyri 2024-10-22 16:03
        
        OT: A choice between BEQool 2024-10-23 11:02
        
        OT: A choice between Helmut 2024-10-23 11:58
        
        OT: A choice betweenBEQool 2024-10-23 13:17
        
        OT: A choice between Helmut 2024-10-23 13:22
        Groups: Overlapping CIs Helmut 2024-11-03 11:36
        
        Groups: Overlapping CIs BEQool 2024-11-05 09:14
        
        Groups: Overlapping CIs Helmut 2024-11-05 10:12
        
        Groups: Overlapping CIs BEQool 2024-11-06 07:44
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-21 13:20
        
        Groups: (Hardly‽) overlapping CIs BEQool 2024-11-22 12:32
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-22 12:58
        Multiplicity? Helmut 2024-11-23 13:05
        
        Groups BEQool 2024-11-26 08:15